Effects of Omeprazole and Caffeine Alone and in Combination with Gentamicin and Ciprofloxacin Against Antibiotic Resistant Staphylococcus Aureus and Escherichia Coli Strains

Bazzaz, Bibi Sedigheh Fazly;Fakori, Mahmoud;Khameneh, Bahman;Hosseinzadeh, Hossein

  • Received : 2018.09.19
  • Accepted : 2019.02.11
  • Published : 2019.03.31


Objective: Antibiotic resistance is a global health problem and threatens health of societies. These problems have led to a search for alternative approaches such as combination therapy. The aim of the present study was to investigate the effect of caffeine and omeprazole in combination with gentamicin or ciprofloxacin against standard and clinically resistant isolates of Staphylococcus aureus and Escherichia coli. Methods: The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of different agents against bacterial strains were determined. The interaction of non- antibiotic drugs with gentamicin and ciprofloxacin was studied in vitro using a checkerboard method and calculating fraction inhibitory concentration index (FICI). Verapamil as efflux pump inhibitor was used to evaluate the possible mechanism of bacterial resistance to antibiotics. Results: The MIC and MBC values of gentamicin against bacterial strains were in the range of $20-80{\mu}g/ml$ and $40-200{\mu}g/ml$, respectively. Caffeine and omeprazole had no intrinsic inhibitory activity against tested microorganisms. However, upon combination of caffeine with antibiotics, the synergistic effects were observed. Verapamil was able to reduce the MIC values of gentamicin (4 folds) only in some bacterial strains. Conclusion: These findings indicated that caffeine was effective in removing bacterial infection caused by S. aureus and E. coli. The relevant mechanisms of antibiotic resistance were not related to the drug efflux.


antimicrobial resistant;omeprazole;caffeine;Escherichia coli;Staphylococcus aureus;antibiotics


  1. Khameneh B, Diab R, Ghazvini K, Fazly Bazzaz BS. Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them. Microb Pathog. 2016;95:32-42.
  2. Khademi F, Poursina F, Hosseini E, Akbari M, Safaei HG. Helicobacter pylori in Iran: A systematic review on the antibiotic resistance. Iran J Basic Med Sci. 2015;18:2-7. Epub 2015/03/27.
  3. Fazly Bazzaz BS, Khameneh B, Zahedian Ostad MR, Hosseinzadeh H. In vitro evaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drug-resistant Staphylococcus aureus and Escherichia coli clinical isolates. Avicenna J Phytomed. 2018;8:246-53.
  4. Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2007;2:323-34.
  5. Corvec S, Tafin UF, Betrisey B, Borens O, Trampuz A. Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother. 2013;57:1421-7.
  6. Fazly Bazzaz BS, Sarabandi S, Khameneh B, Hosseinzadeh H. Effect of Catechins, Green tea Extract and Methylxanthines in Combination with Gentamicin Against Staphylococcus aureus and Pseudomonas aeruginosa: Combination therapy against resistant bacteria. J Pharmacopuncture. 2016;19:312-8.
  7. Forouzanfar F, Bazzaz BS, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci. 2014;17:929- 38. Epub 2015/04/11.
  8. Khameneh B, Fazly Bazzaz BS, Amani A, Rostami J, Vahdati-Mashhadian N. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog. 2016;93:83-7.
  9. Hagihara M, Crandon JL, Nicolau DP. The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms. Expert Opin Drug Saf. 2012;11:221-33. Epub 2011/11/15.
  10. Elgaher WA, Hayallah AM, Salem OIA, Abdel Alim AAM. Synthesis, anti-vbronchoconstrictive, and antibacterial activities of some new 8-substituted-1,3-dimethylxanthine derivatives. Bulletin of Pharmaceutical Sciences. 2009;32:153-87.
  11. Hayallah AM, Elgaher WA, Salem OI, Abdel Alim AAM. Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities. Archives of Pharmacal Research. 2011;34:3-21.
  12. Hosseinzadeh H, Bazzaz F, Ahmadzadeh S. In vitro evaluation of methylxanthines and some antifungal drugs: interaction against Candida albicans. Pharmaceutical and Pharmacological Letters. 2000;11:34-6.
  13. Hosseinzadeh H, Mehrabi M. Effect of R-Phenylpropyladenosine and methylxathines on memory and learning peformance in goldfish. Pharmacologyonline 2009;2:686-689.
  14. Bazzaz BS, Lavaei S, Hosseinzadeh H. Interaction of methylxanthines and gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa: role of phosphodiesterase inhibition. Acta Microbiol Immunol Hung. 2012;59:13-20.
  15. Hosseinzadeh H, Bazzaz BSF, Sadati MM. In vitro evaluation of methylxanthines and some antibiotics: Interaction against Staphylococcus aureus and Pseudomonas aeruginosa. Iranian Biomedical Journal. 2006;10:163-7.
  16. Gyawali R, Adkins A, C. Minor R, Ibrahim SA. Behavior and changes in cell morphology of Escherichia coli O157:H7 in liquid medium and skim milk in the presence of caffeine. CYTA - Journal of Food. 2014;12(3):235-41.
  17. Kim YW, Chun HJ, Kim IW, Liu HB, Ahn WS. Antimicrobial and antifungal effects of green tea extracts against microorganisms causing vaginitis. Food Science and Biotechnology. 2013;22:713-9.
  18. Labbe RG, Nolan LL. Inhibition of macromolecular synthesis by caffeine in Clostridium perfringens. Can J Microbiol. 1987;33:589-92.
  19. Sandlie I, Solberg K, Kleppe K. The effect of caffeine on cell growth and metabolism of thymidine in Escherichia coli. Mutat Res. 1980;73:29-41.
  20. Fleeman RM, Debevec G, Antonen K, Adams JL, Santos RG, Welmaker GS, et al. Identification of a novel polyamine scaffold with potent efflux pump inhibition activity toward multi-drug resistant bacterial pathogens. Front Microbiol. 2018;9:1301. Epub 2018/07/03.
  21. Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:335- 40. Epub 1999/01/30.
  22. Vidaillac C, Guillon J, Arpin C, Forfar-Bares I, Ba BB, Grellet J, et al. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:831-8. Epub 2006/11/15.
  23. Fazly Bazzaz BS, Khameneh B, Namazi N, Iranshahi M, Davoodi D, Golmohammadzadeh S. Solid lipid nanoparticles carrying Eugenia caryophyllata essential oil: the novel nanoparticulate systems with broad-spectrum antimicrobial activity. Lett Appl Microbiol. 2018;66:506-13.
  24. Pacifici GM. Clinical pharmacokinetics of penicillins, cephalosporins and aminoglycosides in the neonate: A review. Pharmaceuticals. 2010;3:2568-91.
  25. Khameneh B, Iranshahy M, Ghandadi M, Ghoochi Atashbeyk D, Fazly Bazzaz BS, Iranshahi M. Investigation of the antibacterial activity and efflux pump inhibitory effect of co- loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus. Drug Dev Ind Pharm. 2015;41:989-94.
  26. Zhang Z, Liu ZQ, Zheng PY, Tang FA, Yang PC. Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori. World J Gastroenterol. 2010;16:1279-84. Epub 2010/03/12.
  27. Cabral V, Luo X, Junqueira E, Costa SS, Mulhovo S, Duarte A, et al. Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives. Phytomedicine. 2015;22:469-76.